This report was recently updated on November 16 2024 with the latest and most recent
market numbers
Global Antibiotic Resistance Market Size, Trends & Analysis - Forecasts to 2026 By Disease (Complicated Urinary Tract Infection (cUTI), Acute Bacterial Skin and Skin Structure Infections (ABSSSI), Hospital Acquired Bacterial Pneumonia/Ventilator (HABP/VABP), Community Acquired Bacterial Pneumonia (CABP), Complicated Intra-Abdominal Infections (cIAI), Blood Stream Infections (BSI), Clostridium difficile infections (CDI)), By End User (Hospitals & Clinics, Research Organizations, Others), By Drug Class (Lipoglycopeptides, Oxazolidinones, Cephalosporins, Tetracyclines, Combination, Others), By Pathogen (Acinetobacter baumannii (Carbapenem-Resistant), Pseudomonas aeruginosa (Carbapenem-Resistant), Staphylococcus Aureus (Methicillin-Resistant), E. coli/K. pneumoniae (Carbapenem-Resistant), Streptococcus pneumoniae (Penicillin-Non-Susceptible), Clostridium difficile (Cephalosporin-Resistant, Tetracycline-Resistant), Enterococcus faecium (Vancomycin-Resistant), Haemophilus Influenzae (Ampicillin-Resistant)), By Region (North America, Europe, Asia Pacific and Rest of the World); Vendor Landscape, End User Landscape and Company Market Share Analysis & Competitor Analysis
Antibiotic Resistance Market: Insights
The global antibiotic resistance market is expected to generate revenue amounting to USD 9,380.29 million in 2020, and is projected to reach to USD 13,531.50 million by 2026, growing at a CAGR of 6.30% over the forecast period. Growing population along with prevalence of chronic diseases across the globe is driving the market growth. Presence of multi-national manufacturers, high burden of antibiotic-resistant infections and emergence of multi-drug resistant pathogens are also some of the major factors expected to propel the market growth during the forecast period.
Increase in the global initiatives to control drug-resistance along with growing number of antibiotics resistance infections in the under developed nations is also driving the market growth for antibiotic resistance. Growing usage of antibiotics across various regions including North America, Europe, Asia Pacific, and Central & South America is further projected to propel the market growth of antibiotic resistance. However, the high treatment cost of is likely to hamper the market growth during the forecast period.
Antibiotic Resistance Market: By Disease
On the basis of disease, the global antibiotic resistance market is segmented into complicated urinary tract infection (CUTI), complicated intra-abdominal infections (CIAI), blood stream infections (BSI), clostridium difficile infections (cdi), acute bacterial skin and skin structure infections (ABSSSI), hospital acquired bacterial pneumonia/ventilator (HABP/VABP), and community acquired bacterial pneumonia (CABP). The complicated urinary tract infection (CUIT) segment was estimated to hold the largest market share during the forecast period. The limited treatment alternatives for complicated urinary tract infections (CUIT) is driving the market growth for the segment. Complicated urinary tract infection happens in individuals with genitourinary tract functional or structural abnormalities. Complicated urinary tract infections (cUTI) are common bacterial infections and a frequent source of primary infection in patients presenting with severe sepsis or septic shock.
Antibiotic Resistance Market: By Pathogen
On the basis of pathogen, the market is segmented into acinetobacter baumannii (carbapenem-resistant), pseudomonas aeruginosa (carbapenem-resistant), staphylococcus aureus (methicillin-resistant), e. coli/k. pneumoniae (carbapenem-resistant), streptococcus pneumoniae (penicillin-non-susceptible), clostridium difficile (cephalosporin-resistant, tetracycline-resistant), enterococcus faecium (vancomycin-resistant), and haemophilus influenzae (ampicillin-resistant). The e. coli/k. pneumoniae (carbapenem-resistant) was estimated to hold the largest market share and is projected to grow at the highest CAGR during the forecast period. E. Coli and K. Pneumoniae have been studied for the determination of the molecular resistance mechanism. It focuses on antibiotic resistance in seven specific bacteria responsible for common serious diseases such as infections with the bloodstream, diarrhea, pneumonia, UTIs, and gonorrhea, among others.
Antibiotic Resistance Market: By Drug Class
On the basis of drug class, the market is segmented into oxazolidinones, lipoglycopeptides, tetracyclines, cephalosporins, and combination among others. The cephalosporins segment was estimated to hold the largest market share during the forecast period. Cephalosporins are a large group of antibiotics that belong to a class known as beta-lactam antibiotics. Cephalosporins are bactericidal and function similarly to penicillins. These drugs are used to treat bacterial infections including ear infections, pneumonia, skin infections, and kidney infections, among others. The combination segment is expected to grow at a high CAGR during the forecast period. A combination drug or a mixture of fixed doses (FDC) is a drug that contains two or more active ingredients incorporated in a single dosage type. They are widely used in human and veterinary medicine, among others.
Antibiotic Resistance Market: By End User
Based on the end-user, the antibiotic resistance is segmented into hospitals & clinics, and research organizations, among others. The hospitals & clinics segment is anticipated to hold the largest market share in terms of revenue during the forecast period.
Antibiotic Resistance Market: By Region
On the basis of region, the global antibiotic resistance market is segmented into North America, Europe, Asia Pacific, Middle East Africa and Central & South America. The North America antibiotic resistance market is expected to dominate the global market. Numerous drug launches in the market and high treatment cost are supplementing the growth of the regional market. The availability of better medical facilities in the U.S and increasing healthcare expenditure are some of the major factors driving the market growth in the region. The Asia Pacific region is expected to grow at a high CAGR during the forecast period. High prevalence of bacterial infection in countries such as India and China are driving the market growth in the region.
Antibiotic Resistance Market: End Use Landscape
The end-user landscape entails a list of current and prospective consumers prevailing across the regions. This section briefs you about company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase antibiotic resistance. The key end-users of the markets are Chang Gung Memorial Hospital and Mayo Clinic, among others.
Antibiotic Resistance Market: Vendor Landscape
The report contains a chapter dedicated to vendors operating in the market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies.
Antibiotic Resistance Market: Share & Competitor Analysis
Some of the key players operating in the antibiotic resistance market are Basilea Pharmaceutica Ltd., Melinta Therapeutics, Tetraphase Pharmaceuticals, Inc., Theravance Biopharma, Inc., Wockhardt therapeutics, Entasis Therapeutics, PARATEK Therapeutics, and Seres Therapeutics, Inc., Merck & Co. Inc., Novartis AG, Johnson and Johnson, Pfizer Inc., BioFlim Pharma, among others.
Please note: This is not an exhaustive list of companies profiled in the report.
Check the Press Release on Global Antibiotic Resistance Market Report
Antibiotic Resistance Market: By Disease
Antibiotic Resistance Market: By Drug Class
Antibiotic Resistance Market: By Pathogen
Antibiotic Resistance Market: By Region
The global Antibiotic Resistance Market has been studied from the year 2017 till 2026. However, the CAGR provided in the report is from the year 2018 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Antibiotic Resistance Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
